Polymer Market To Hit $3.5bn In 2018
The value of the global medical
polymer market is set to rise by more than half in the next five years, boosted
by an ageing population and developing markets.
The market will grow from $2.3bn
(•1.7bn) to more than $3.5bn (•2.6bn), a rise of more than 52%, between now and
Lower in cost and lighter than
metallic alternatives such as titanium, medical polymers are proving popular
among device manufacturers and the medical profession alike.
Meanwhile sales of polymers
destined for diagnostic systems will likely reach around $1.04bn (•0.8bn) in
In vitro diagnostics account for
between 50,000 and 60,000 tonnes of specialised and commodity plastics annually.
Leading medical polymers include
PMMA, PS/styrenics and polypropylene, while the market is seeing the increased
use of more ‘comfortable’ material, such as elastomers, to provide a ‘soft
touch’ feel to products.
Even entire prostheses perhaps
will increasingly be made from biodegradable polymers.